Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

According to the researchers, Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition that is ...

Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...

Levels of respiratory illnesses in the Sheboygan area are high, on trend with regional and state data, according to Sheboygan ...

Jay Bhattacharya Will Bring Transparency to NIH . Dr. Andrew Noymer is an epidemiologist and population health scientist who ...

To date clinical studies often show a poor B cell-mediated antibody response after an infection or vaccination in those with ...

Oregon’s timber industry worked for decades to clear-cut and replant forests, turning vast swaths of the state into tree plantations and wood into a crop. Conservationists protested disappearing ...